Dentsply Sirona Inc. has issued investment-grade corporate bonds currently yielding 8.5%, making them among the highest-yielding securities in the dental products sector. The bonds carry an S&P rating of BBB– and a Moody’s rating of Baa3, offering a spread of approximately 450 basis points over U.S. Treasuries. With a remaining maturity of 7 years and no major debt maturities until 2028, these bonds provide a compelling risk-adjusted return for income-focused portfolios seeking exposure to a globally diversified medical devices issuer.

Operating in more than 100 countries, Dentsply Sirona’s revenue is split across four reporting segments: Connected Technology Solutions (22% of 2025 sales), Orthodontic and Implant Solutions (28%), Essential Dental Solutions (45%), and Wellspect Healthcare (5%). In fiscal 2025, the Connected Technology unit grew sales 7.2% year-over-year, driven by adoption of intraoral scanners and CAD/CAM chairside mills, while the Orthodontic and Implant segment posted flat revenue due to inventory destocking in North America. Essential Dental Solutions recorded a modest 1.5% decline, reflecting price pressure on consumables in Europe, and Wellspect contributed stable, low-double-digit growth in emerging markets.

As of Q3 2025, Dentsply Sirona reported net debt of $3.2 billion against trailing twelve-month EBITDA of $800 million, yielding a net leverage ratio of 4.0x. Interest coverage stands at 4.5x, supported by disciplined capital expenditure of $150 million last year and free cash flow generation of $350 million. Management forecasts further deleveraging to a 3.5x ratio by the end of 2026, assuming stable organic revenue growth of 3–5% and continued cost-savings initiatives expected to deliver $75 million in annualized run-rate benefits.

Looking ahead, management has outlined a three-pillar strategy: accelerate digital solutions rollout, optimize global supply chain footprint, and pursue bolt-on acquisitions in high-growth markets such as India and Latin America. Analysts estimate revenue growth of 4%–6% in 2026, with adjusted EBITDA margin expansion of 50–75 basis points. For bondholders, potential upgrades to BBB by S&P or Baa2 by Moody’s could drive further yield compression. Equity investors may view the 8.5% bond yield as a signal of cautious market sentiment, but the company’s sizable recurring consumables business and backlog of digital equipment orders underpin a resilient cash flow profile.